18 results
POS AM
LSB
LakeShore Biopharma Co., Ltd
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
with regulatory approvals of offshore offerings, anti-monopoly regulatory actions, oversight on cybersecurity and data privacy, as well as the lack … could have an adverse effect on YS Group’s business and results of operations.
YS Group and its CROs are subject to stringent privacy laws, information
424B3
LSB
LakeShore Biopharma Co., Ltd
15 Aug 23
Prospectus supplement
8:00am
, oversight on cybersecurity and data privacy, as well as the lack of PCAOB inspection on its auditors. On December 16, 2021, the PCAOB issued a report … are subject to stringent privacy laws, information security policies and contractual obligations related to data privacy and security, and YS Group may
POS AM
xwga 3e2xbdyrdfle
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
20-F
q08545t hrjr
26 Jul 23
Annual report (foreign)
4:02pm
20-F
EX-2.1
1u42a qatz6w7wgzi
26 Jul 23
Annual report (foreign)
4:02pm
424B3
woucwr
5 Jun 23
Prospectus supplement
4:03pm
F-1/A
brep4jpmenrdxci f7o
12 May 23
Registration statement (foreign) (amended)
4:05pm
F-1
0a70hz
12 Apr 23
Registration statement (foreign)
8:49am
F-4
EX-99.2
4dr2nhv088dqt
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
fhyk1vq66 svn4h84z
28 Dec 22
Registration of securities (foreign)
6:58am
DRS/A
1v9 o90rq8yakm1bfx
7 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
m4wbf3kj
14 Nov 22
Draft registration statement (amended)
12:00am
DRS
9gkft7dgvg joy
3 Oct 22
Draft registration statement
12:00am
425
EX-99.2
43gv5wc
30 Sep 22
Business combination disclosure
9:25am
425
EX-2.1
pc11ueh76dk7i4bvgdau
30 Sep 22
Business combination disclosure
9:25am
- Prev
- 1
- Next